{
    "Orphapacket": {
        "ORPHApacketId": "413674",
        "creationDate": "2022-11-28 11:04:13",
        "version": "1.3.18 / 4.1.7 [2022-07-12] (orientdb version)",
        "copyright": "Orphanet (c) 2022",
        "ORPHAcode": "413674",
        "Label": "Prediction of toxicity or dose selection of vitamin K antagonists",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_413674",
        "DisorderType": {
            "value": "Particular clinical situation in a disease or syndrome",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_377793"
        },
        "Genes": [
            {
                "Gene": {
                    "Symbol": "CYP2C9",
                    "Name": "cytochrome P450 family 2 subfamily C member 9",
                    "ExternalReferences": []
                }
            },
            {
                "Gene": {
                    "Symbol": "CYP4F2",
                    "Name": "cytochrome P450 family 4 subfamily F member 2",
                    "ExternalReferences": []
                }
            },
            {
                "Gene": {
                    "Symbol": "VKORC1",
                    "Name": "vitamin K epoxide reductase complex subunit 1",
                    "ExternalReferences": []
                }
            }
        ],
        "Parents": {
            "Parent": [
                {
                    "ORPHAcode": "231957",
                    "Label": "Disease associated with a genetic susceptibility or tested for a biomarker"
                }
            ]
        }
    }
}